Boston Scientific sets its eyes on emerging APAC markets

The new facility at Gurgaon marks a strategic investment by Boston Scientific. The Research and Development (R&D) Center will focus on creating market-appropriate products based on unmet clinical needs in emerging markets


New Delhi: The recent inauguration of 100,000 sq. ft. research and development, training and commercial center by Boston Scientific will enable it to develop and sell minimally invasive technologies fit for India and the greater Asian market, and train physicians in using them effectively. The state-of-the-art Institute for Advancing Science (IAS), a physician training facility equipped with world-class simulators for hands-on training on innovative technologies, is the newest addition to the growing global network of Boston Scientific IAS facilities.

As a key country in the company’s emerging market strategy, India’s improving economic conditions and healthcare access show potential for the growth of the local healthcare industry and need for medical devices. By establishing a consolidated presence in the region, Boston Scientific will extend its reach in India, offering solutions to physicians and patients combatting conditions in areas such as cardiovascular disease, cardiac arrhythmias, gastrointestinal and urologic disorders, and chronic pain.

Boston Scientific FacilityThe launch on July 15th was attended by Mr Faggan Singh Kulaste, minister of state for health and family welfare, Capt. Abhimanyu, finance minister, government of Haryana, and Mr John M. McCaslin, minister counselor for commercial affairs, United States Embassy, New Delhi.


Also present at the launch were several of the country’s top physicians, representatives from the health sector, partner organizations, academia and members of industry associations such as The National Association of Software and Services Companies, US India Business Council, American Chamber of Commerce, the Federation of Indian Chambers of Commerce and Industry, NATHEALTH, MTaI and the Confederation of Indian Industry.

The health minister Kulaste said, “The need for innovation in medical technology is a high priority in many countries worldwide, and the government will support all efforts in research and innovation so that affordable and quality care is accessible to more and more patients in India.”

“India is an important market and it holds great potential for the global medical devices industry,” said Mr Prabal Chakraborty, vice president and managing director for Boston Scientific in India. “The Indian ecosystem has all the right ingredients for innovation, namely a best-in-class technical talent pool in the areas of STEM (Science, Technology, Engineering and Math), world-renowned physicians who bring an understanding of clinical unmet needs, and top-notch academic institutions.

We plan to tap into the high caliber talent pool and the innovation ecosystem to deliver cutting-edge medical device innovation. The launch of this facility underscores our commitment to India, and we are confident that our R&D activities will address many of the current health challenges of the country and the world.”

The new facility marks a strategic investment by Boston Scientific. The Research and Development (R&D) Center will focus on creating market-appropriate products based on unmet clinical needs in emerging markets, and will also serve as a global product engineering center.

At the opening ceremony, Mr Kulaste flagged off the Boston Scientific Navigation Express, an innovation mobile van that will travel through 11 states, 53 cities, and 206 hospitals in six months to educate physicians, hospital administrators, and medical technicians on the new range of medical devices available today to enhance diagnosis and treatment efficacy in order to improve patient outcomes.

Boston Scientific has been operating in India since 2003. It says that it has been transforming lives through innovative medical solutions that improve the health of patients around the world. As a global medical technology leader for more than 35 years, it claims to advance science for life by providing a broad range of high performance solutions that address unmet patient needs and reduce the cost of healthcare.